Seeking Alpha

CVS Caremark earnings call: Dissecting the tobacco exit

  • Execs with CVS Caremark (CVS -0.3%) cleared up some of the haze over what the impact of the exit of from the tobacco business will be during the firm's earnings call.
  • CVS lost 110 bps from its front store comp sales mark during Q2 and the development contributed to an overall loss in market share for drugstore traffic.
  • A 400-500 bp loss in front store sales growth is expected in Q3.
  • Overall, CVS says it will lose $2B in annual sales from the tobacco decision.
  • There isn't any specific guidance from the company on how much of the $2B will be made up and when by signing new healthcare services and provider deals.
  • Earnings call transcript
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|